Cardiovascular Drugs Not Price Aligned with Value in U.S.

Drug Pricing Lab
August 21, 2018

Cost-effectiveness influences drug prices in developed countries outside of the U.S. In published research conducted by Drug Pricing Lab’s visiting investigator Dr. Andrew H Briggs and colleagues, U.S. prices of common cardiovascular drugs are not consistent with the cost-effectiveness evidence. Full article here.